The Risk of Developing Myocarditis Among Males Ages 16 to 19 Years Are About One in 15,000 ... - Latest Tweet by IANS India

The risk of developing myocarditis among males ages 16 to 19 years are about one in 15,000 after the third dose of the #Pfizer-#BioNTech Covid-19 vaccine, however the cases are rare and mild, according to a new research conducted in Israel.#COVID19 pic.twitter.com/kEKizI1EsP— IANS (@ians_india) September 6, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)